Bellevue Life Sciences Stock Current Valuation
| BLAC Stock | 11.30 0.04 0.36% |
Valuation analysis of Bellevue Life Sciences helps investors to measure Bellevue Life's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Over EBITDA is expected to grow to 65.61. The current year's Enterprise Value Multiple is expected to grow to 65.61. Fundamental drivers impacting Bellevue Life's valuation include:
Price Book 3.0618 | Enterprise Value 47.4 M | Enterprise Value Ebitda (98.70) |
Overvalued
Today
Please note that Bellevue Life's price fluctuation is not too volatile at this time. Calculation of the real value of Bellevue Life Sciences is based on 3 months time horizon. Increasing Bellevue Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bellevue Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bellevue Stock. However, Bellevue Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.3 | Real 9.61 | Hype 11.3 |
The real value of Bellevue Stock, also known as its intrinsic value, is the underlying worth of Bellevue Life Sciences Company, which is reflected in its stock price. It is based on Bellevue Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bellevue Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bellevue Life Sciences helps investors to forecast how Bellevue stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bellevue Life more accurately as focusing exclusively on Bellevue Life's fundamentals will not take into account other important factors: Bellevue Life Sciences Company Current Valuation Analysis
Bellevue Life's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bellevue Life Current Valuation | 47.43 M |
Most of Bellevue Life's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bellevue Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bellevue Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Bellevue Life is extremely important. It helps to project a fair market value of Bellevue Stock properly, considering its historical fundamentals such as Current Valuation. Since Bellevue Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bellevue Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bellevue Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bellevue Life Sciences has a Current Valuation of 47.43 M. This is 99.86% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The current valuation for all United States stocks is 99.71% higher than that of the company.
Bellevue Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bellevue Life's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bellevue Life could also be used in its relative valuation, which is a method of valuing Bellevue Life by comparing valuation metrics of similar companies.Bellevue Life is currently under evaluation in current valuation category among its peers.
Bellevue Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bellevue Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bellevue Life's managers, analysts, and investors.Environmental | Governance | Social |
Bellevue Fundamentals
| Return On Asset | -0.0298 | ||||
| Current Valuation | 47.43 M | ||||
| Shares Outstanding | 4.04 M | ||||
| Shares Owned By Insiders | 50.49 % | ||||
| Shares Owned By Institutions | 42.94 % | ||||
| Number Of Shares Shorted | 517 | ||||
| Price To Book | 3.06 X | ||||
| EBITDA | 944.59 K | ||||
| Net Income | 403.78 K | ||||
| Total Debt | 4.11 M | ||||
| Book Value Per Share | (0.69) X | ||||
| Cash Flow From Operations | (818.77 K) | ||||
| Short Ratio | 0.04 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Market Capitalization | 45.67 M | ||||
| Total Asset | 36.63 M | ||||
| Retained Earnings | (3.91 M) | ||||
| Working Capital | (2.02 M) | ||||
| Net Asset | 36.63 M |
About Bellevue Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bellevue Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bellevue Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bellevue Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bellevue Life Sciences is a strong investment it is important to analyze Bellevue Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bellevue Life's future performance. For an informed investment choice regarding Bellevue Stock, refer to the following important reports:Check out Bellevue Life Piotroski F Score and Bellevue Life Altman Z Score analysis. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellevue Life. If investors know Bellevue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellevue Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Return On Assets (0.03) |
The market value of Bellevue Life Sciences is measured differently than its book value, which is the value of Bellevue that is recorded on the company's balance sheet. Investors also form their own opinion of Bellevue Life's value that differs from its market value or its book value, called intrinsic value, which is Bellevue Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellevue Life's market value can be influenced by many factors that don't directly affect Bellevue Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellevue Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bellevue Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellevue Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.